5 things to watch on the ASX 200 on Friday

The ASX 200 is expected to end the week with a small gain.

Business woman watching stocks and trends while thinking

Image Source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

On Thursday, the S&P/ASX 200 Index (ASX: XJO) was out of form and dropped into the red. The benchmark index fell 0.6% to 6,812.3 points.

Will the market be able to bounce back from this on Friday and end the week on a high? Here are five things to watch:

ASX 200 expected to edge higher

The Australian share market looks set to end the week on a mildly positive note despite another poor session on Wall Street. According to the latest SPI futures, the ASX 200 is expected to open 12 points or 0.2% higher this morning. In late trade on the United States, the Dow Jones is down 0.55%, the S&P 500 is down 1%, and the NASDAQ is down 1.55%.

Oil prices fall

ASX 200 energy shares Beach Energy Ltd (ASX: BPT) and Woodside Energy Group Ltd (ASX: WDS) could end the week in the red following a poor night for oil prices. According to Bloomberg, the WTI crude oil price is down 2.6% to US$83.09 a barrel and the Brent crude oil price is down 2.6% to US$87.82 a barrel. Demand concerns weighed on oil prices.

ResMed quarterly update

The ResMed Inc (ASX: RMD) share price will be on watch today when the sleep treatment company releases its quarterly update. All eyes will be on management's commentary regarding the rise of wonder drugs like Ozempic. Concerns about these GLP-1 drugs are why the company's shares have been sold off in recent months.

Gold price edges lower

ASX 200 gold miners including Evolution Mining Ltd (ASX: EVN) and Northern Star Resources Ltd (ASX: NST) could have a soft finish to the week after the gold price edged lower overnight. According to CNBC, the spot gold price is down 0.1% to US$1,993.6 an ounce. Strong US economic data put pressure on gold.

Allkem shares named as buy

Goldman Sachs believes Allkem Ltd (ASX: AKE) shares are undervalued. In response to the lithium miner's first-quarter update, the broker has reiterated its buy rating with a trimmed price target of $14.40. It said: "Long-term organic growth optionality remains undervalued."

Motley Fool contributor James Mickleboro has positions in Allkem and ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group and ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

a woman with lots of shopping bags looks upwards towards the sky as if she is pondering something.
Opinions

The pros and cons of buying Zip shares in 2026

There are positive and negative aspects about Zip shares right now…

Read more »

A happy male investor turns around on his chair to look at a friend while a laptop runs on his desk showing share price movements
Broker Notes

Buy, hold, sell: CBA, REA Group, and Xero shares

Morgans has given its verdict on these popular stocks. Let's see if it is bullish on them.

Read more »

A man in a suit looks serious while discussing business dealings with a couple as they sit around a computer at a desk in a bank home lending scenario.
Share Market News

Here's what Westpac says the RBA will do with interest rates in 2026

Stick or twist? Let's see what the RBA could do with rates this year.

Read more »

A woman stretches her arms into the sky as she rises above the crowd.
Best Shares

Fastest rising ASX 200 share of each market sector in 2025

These shares outperformed their sector peers last year.

Read more »

A couple stares at the tv in shock, with the man holding the remote up ready to press a button.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man goes over his finances and investment portfolio at home.
Broker Notes

Buy, hold, sell: Aristocrat, James Hardie, and TechnologyOne shares

Morgans has given its verdict on these popular shares. Is it bullish, bearish, or something in between?

Read more »

Group of entrepreneurs feeling frustrated during a meeting in the office. Focus is on man with headache.
Share Fallers

5 worst ASX All Ords shares of 2025, and why brokers rate 4 of them a buy

The ASX All Ords rose by 7.11% in 2025 but as always, there were losers in the pack.

Read more »

A female soldier flies a drone using hand-held controls.
Best Shares

These 5 ASX All Ords shares were the fastest risers of 2025

The ASX All Ords rose by 7.11% and delivered total returns, including dividends, of 10.56% in 2025.

Read more »